Bath & Body Works (NYSE:BBWI – Get Free Report) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 1.940-2.070 for the period, compared to the consensus estimate of 1.970. The company issued revenue guidance of $2.7 billion-$2.8 billion, compared to the consensus revenue estimate of $2.7 billion. Bath & Body Works also updated its Q4 guidance to $1.94-2.07 EPS.
Bath & Body Works Stock Performance
Shares of NYSE:BBWI opened at $35.92 on Thursday. The firm has a market cap of $7.87 billion, a price-to-earnings ratio of 8.76, a P/E/G ratio of 1.14 and a beta of 1.79. The firm has a fifty day moving average price of $30.81 and a 200 day moving average price of $35.65. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, research analysts predict that Bath & Body Works will post 3.18 earnings per share for the current year.
Bath & Body Works Dividend Announcement
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on the stock. Raymond James cut their target price on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Deutsche Bank Aktiengesellschaft upped their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday. Wells Fargo & Company boosted their price objective on Bath & Body Works from $32.00 to $38.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Finally, Citigroup dropped their target price on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a report on Tuesday, August 20th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $41.88.
View Our Latest Analysis on Bath & Body Works
Insider Buying and Selling at Bath & Body Works
In other news, CEO Gina Boswell acquired 6,000 shares of Bath & Body Works stock in a transaction on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.27% of the stock is owned by corporate insiders.
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
See Also
- Five stocks we like better than Bath & Body Works
- How to Calculate Return on Investment (ROI)
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
- Which Wall Street Analysts are the Most Accurate?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Stock Splits, Do They Really Impact Investors?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.